References of "Scheen, A. J"
     in
Bookmark and Share    
Full Text
See detailLe traitement du diabète de type 2: entre insulinosensibilisateurs et insulinosécrétagogues
Scheen, A. J.; Radermecker, R. P.; Philips, J. C. et al

in Revue Médicale de Liège (2007), 62 Spec No

Type 2 diabetes is a complex disease characterized by a dual defect of insulin secretion and insulin sensitivity, which may vary from patient to patient, but also along the natural history of the disease ... [more ▼]

Type 2 diabetes is a complex disease characterized by a dual defect of insulin secretion and insulin sensitivity, which may vary from patient to patient, but also along the natural history of the disease in a particular patient. Besides the lifestyle changes, the treatment strategy comprises the administration of agents that promote insulin secretion and/or that improve insulin sensitivity. Drugs facilitating weight loss also improve glucose control by reducing insulin resistance. A global approach should be recommended to reduce the high cardiovascular risk of diabetic patients. The present article aims at summarizing our contribution to the development of drugs designed for the treatment of type 2 diabetes. [less ▲]

Detailed reference viewed: 92 (4 ULg)
Full Text
See detailPhysiopathologie de l'hyperglycemie post-prandiale
Scheen, A. J.; Paquot, Nicolas ULg

in Journées Annuelles de Diabetologie de l'Hôtel-Dieu (2006)

Detailed reference viewed: 18 (0 ULg)
See detailComment j'explore ... nouveaux critères pour le diagnostic du diabète sucré
Scheen, A. J.; Paquot, Nicolas ULg; Lefebvre, P. J.

in Revue Médicale de Liège (1997), 52(9), 606-9

Detailed reference viewed: 2 (0 ULg)
See detailLa dépense énergétique chez l'homme
Bustin, F.; Pestieau, S. R.; Paquot, Nicolas ULg et al

in Revue Médicale de Liège (1997), 52(2), 101-4

Detailed reference viewed: 3 (1 ULg)
See detailComment évaluer la sécrétion insulinique en pratique?
Scheen, A. J.; Paquot, Nicolas ULg; Letiexhe, M. R. et al

in Diabète & Métabolisme (1995), 21(6), 458-64

Detailed reference viewed: 7 (0 ULg)
See detailLe cas clinique du mois. Rémission spontanée prolongée d'un diabète de type 1 typique
Scheen, A. J.; Letiexhe, M. R.; Paquot, Nicolas ULg et al

in Revue Médicale de Liège (1995), 50(9), 363-4

Detailed reference viewed: 16 (0 ULg)
See detailHow to Measure Insulin Action in Vivo
Scheen, A. J.; Paquot, Nicolas ULg; Castillo, M. J. et al

in Diabetes/Metabolism Reviews (1994), 10(2), 151-88

Detailed reference viewed: 11 (0 ULg)
See detailLe diabète de type 2 insulinorequérant: caractéristiques des patients et effets de l'insulinothérapie
Duysinx, Bernard ULg; Scheen, A. J.; Paquot, Nicolas ULg et al

in Revue Médicale de Liège (1994), 49(6), 305-23

Detailed reference viewed: 8 (0 ULg)
See detailTransfert des insulines U40 aux insulines U100: comparaison des profils insulinémiques et glycémiques chez le patient diabétique
Scheen, A. J.; Guiot, Julien; Stassen, M. P. et al

in Revue Médicale de Liège (1991), 46(4), 181-7

Detailed reference viewed: 7 (0 ULg)
See detailLa cellule beta dans le diabète de type II: coupable ou victime?
Scheen, A. J.; Paquot, Nicolas ULg; Lefebvre, P. J.

in Journées Annuelles de Diabetologie de l'Hôtel-Dieu (1991)

Detailed reference viewed: 4 (0 ULg)